Browsing by Author "Djukanovic, Ljubica (7006214786)"
Now showing 1 - 4 of 4
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Association of SOD2 (Rs4880) and GPX1 (rs1050450) gene polymorphisms with risk of Balkan endemic nephropathy and its related tumors(2019) ;Dragicevic, Biljana (57190872935) ;Suvakov, Sonja (36572404500) ;Jerotic, Djurdja (57209718540) ;Reljic, Zorica (8655358500) ;Djukanovic, Ljubica (7006214786) ;Zelen, Ivanka (8436760800) ;Pljesa-Ercegovac, Marija (16644038900) ;Savic-Radojevic, Ana (16246037100) ;Simic, Tatjana (6602094386) ;Dragicevic, Dejan (6506794751)Matic, Marija (58618962300)Background: Experimental data show that superoxide dismutase 2 (SOD2) is involved in ochratoxin (OTA)-induced nephrotoxicity, whereas clinical data indicate the role of SOD2 rs4880 or glutathione peroxidase 1 (GPX1) rs1050450 polymorphisms in end-stage renal disease and urothelial carcinoma risk, known to be the major complications of Balkan endemic nephropathy (BEN). Therefore, we hypothesized that SOD2 and GPX1 gene polymorphisms would influence the risk of BEN and its associated tumors. Materials and Methods: The study was conducted in 207 BEN patients and 86 controls from endemic areas. Results: Individuals with both copies of variant SOD2 allele, known for lower mitochondrial antioxidant protection, are at a significantly higher BEN risk (OR = 2.6, p = 0.021). No association was observed between GPX1 gene polymorphism and BEN risk. Combining SOD2 and GPX1 genotypes did not alter the risk of BEN development. Regarding the risk of urothelial tumors in BEN patients, none of the polymorphisms studied was significantly associated with the risk of these tumors. Conclusions: Polymorphism in SOD2 rs4880 gene affects the risk of BEN development. Hence, SOD2 genotyping could, together with a panel of other enzymes, be used as a biomarker of susceptibility in BEN areas. © 2019 by the authors. Licensee MDPI, Basel, Switzerland. T. - Some of the metrics are blocked by yourconsent settings
Publication Comparison of accepted and unaccepted living kidney donors: One-center experience(2018) ;Kezić, Aleksandra (16550282700) ;Kovačević, Svetlana (57196510563) ;Marinkovič, Jelena (7004611210) ;Ristić, Stojanka (7003672541) ;Radivojević, Dragana (12778572600) ;Blagojević-Lazić, Radmila (6603255863) ;Djukanovic, Ljubica (7006214786)Ležaić, Visnja D. (55904881900)Background: Kidney transplantation from living donors (LD) has stagnated in many countries. This study aimed to check whether correction of LD selection practice could increase the number of kidney transplantations. Methods: From January 2003 to December 2012, 241 potential adult LD were evaluated in our hospital. Outcome (mortality and end-stage renal disease-ESRD) of accepted LD (182) was compared with unaccepted (59) donors. Results: Mortality of LD was comparable with that for the standardized Serbian population (SMR¼1.104; 95% CI (0.730–1.606). Among evaluated potential LD, almost every fourth had been unaccepted, but reasons were modifiable in 42.4% of them. In pre-donation period unaccepted donors were significantly older, measured glomerular filtration rate was lower, with higher 15-year and lifelong projected ESRD risks than accepted donors. Despite this, ten years outcome of both groups LD was similar: none of LD developed ESRD, 9.8% of accepted and 11.8% of unaccepted LD died (p¼.803). Conclusions: During an average of 101 months of follow-up mortality of accepted LD did not differ significantly as compared to the age standardized Serbian population and none of them developed ESRD. In examination of potential LD, the use of accurate and precise methods for kidney function estimation and the evaluation of risk for ESRD and mortality as well as treatment of modifiable contraindications for kidney donation are necessary. © 2018 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication Recording blood pressure and eGFR in primary care after the belgrade screening study(2018) ;Lezaic, Visnja (55904881900) ;Marinkovic, Jelena (7004611210) ;Milutinovic, Zoran (57203807180) ;Jovanovic-Vasiljevic, Nada (57203802137) ;Vujicic, Vesna (57203807318) ;Pejovic, Branka (57203899439) ;Kalabic, Snezana (57203806806)Djukanovic, Ljubica (7006214786)Background: In 2009, Belgrade nephrologists and general practitioners from thirteen health centers carried out screening for chronic kidney disease (CKD). Three years later, medical records of patients from four health centers participating in the screening study were retrospectively analyzed in order to check whether general practitioners had continued to control patients at risk for CKD in accordance with the recommendations provided. Methods: The study included 460 patients who visited their doctor at least once in the threeyear period. Data on blood pressure, ACEI use, estimated glomerular filtration rate (eGFR) and comorbidities were taken from patients’ medical records. Results: Blood pressure was not recorded in any of the three years in 42.8% and eGFR in 36.7% of the patients, but blood pressure was registered every year in 7.8% and eGFR in 4.3% of them. Over the three years, the relative number of patients with recorded blood pressure decreased from 41.7% to 17.8%, and with recorded eGFR from 41.7% to 21.5%. Multivariate linear regression found that Health Center, systolic and diastolic blood pressure and presence of hypertension were negatively associated with number of years with recorded blood pressure. Health Center, systolic blood pressure and sum of years with recorded eGFR below 60 ml/min/1.73m2 were associated with number of years with recorded eGFR. Conclusions: Under-recording of blood pressure and eGFR in primary care health centers suggests lack of adherence to current guidelines and insufficient care of CKD patients. This implies the necessity for continuous education of physicians. © 2018 The Author(s). - Some of the metrics are blocked by yourconsent settings
Publication The GSTO2 (rs156697) Polymorphism Modifies Diabetic Nephropathy Risk(2023) ;Pavlovic, Dragana (55180781100) ;Ristic, Sinisa (17136405900) ;Djukanovic, Ljubica (7006214786) ;Matic, Marija (58618962300) ;Kovacevic, Marijana (55180462000) ;Pljesa-Ercegovac, Marija (16644038900) ;Hadzi-Djokic, Jovan (6603561960) ;Savic-Radojevic, Ana (16246037100)Djukic, Tatjana (36193753800)Background and Objectives: In the development of type 2 diabetes mellitus (T2DM) and its complications, genetic and environmental factors play important roles. Diabetic nephropathy (DN), one of the major microangiopathic chronic diabetic complications, is associated with an increased risk of major cardiovascular events and all-cause mortality. The present study was designed to investigate the possible modifying effect of glutathione transferase polymorphisms (GSTM1, GSTT1, GSTP1 rs1138272/rs1695, GSTO1 rs4925 and GSTO2 rs156697) in the susceptibility to T2DM and diabetic nephropathy. Materials and Methods: GSTM1 and GSTT1 deletion polymorphisms were determined by multiplex PCR, whereas GSTO1, GSTO2, and GSTP1 polymorphisms were determined by the real-time PCR in 160 T2DM patients and 248 age- and gender-matched controls. Advanced glycation end products (AGEs) were measured by ELISA. Results: Among six investigated GST polymorphisms, a significant association between the GST genotypes and susceptibility for development of diabetes mellitus was found for the GSTM1, GSTT1, GSTP1 (rs1138272) and GSTO1 polymorphisms. When the GST genotypes’ distribution in diabetes patients was assessed in the subgroups with and without diabetic nephropathy, a significant association was found only for the GSTO2 rs156697 polymorphism. Diabetic patients, carriers of the GSTM1 null, GSTT1 null and variant GSTO1*AA genotypes, had significantly increased levels of AGEs in comparison with carriers of the GSTM1 active, GSTT1 active and referent GSTO1*CC genotypes (p < 0.001, p < 0.001, p = 0.004, respectively). Conclusions: The present study supports the hypothesis that GST polymorphisms modulate the risk of diabetes and diabetic nephropathy and influence the AGEs concentration, suggesting the potential regulatory role of these enzymes in redox homeostasis disturbances. © 2023 by the authors.
